AdjuTec-Therapeutics Overview
- Year Founded
-
2017
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
AdjuTec-Therapeutics General Information
Description
Developer of immunotherapy designed to effectively treat pancreatic, liver, and bile duct cancers. The company's therapy addresses a high unmet medical need and is scalable to other cancers such as liver, bile duct, and esophagus, enabling patients to fight against diseases.
Contact Information
Website
www.adjutec-therapeutics.comCorporate Office
- Oxfordlaan 55
- 6229 EV Maastricht
- Netherlands
Corporate Office
- Oxfordlaan 55
- 6229 EV Maastricht
- Netherlands
AdjuTec-Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Out of Business | 09-Aug-2025 | Completed | Out of Business | |||
| 1. Early Stage VC | Completed | Startup |
AdjuTec-Therapeutics FAQs
-
When was AdjuTec-Therapeutics founded?
AdjuTec-Therapeutics was founded in 2017.
-
Where is AdjuTec-Therapeutics headquartered?
AdjuTec-Therapeutics is headquartered in Maastricht, Netherlands.
-
What industry is AdjuTec-Therapeutics in?
AdjuTec-Therapeutics’s primary industry is Drug Discovery.
-
Is AdjuTec-Therapeutics a private or public company?
AdjuTec-Therapeutics is a Private company.
-
What is AdjuTec-Therapeutics’s current revenue?
The current revenue for AdjuTec-Therapeutics is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process